Ascorbic-acid Treatment for Progressive Bone Metastases After Radiotherapy: A Pilot Study

Thumbnail
Date
2014-01-01
Author
MAYADAGLI, Alparslan
Kiziltan, HURİYE ŞENAY
TAŞPINAR, Ozgur
Meral, Ismail
Eris, ALİ HİKMET
Bayir, Ayse Gunes
DEMİRTAŞ, Murat
Aydin, TEOMAN
Advisor
Type
Metadata
Show full item record
Abstract
Context Researchers have reported improved survival rates for patients with cancer when 10-75 g of vitamin C (ascorbic acid, or AA) is administered intravenously. AA exhibits a cytotoxic effect upon entering a cancer cell.
Subject
URI
https://hdl.handle.net/20.500.12645/1666
Collections